These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30006436)

  • 21. National survey of quality assurance activities for pharmacy-compounded sterile preparations.
    Morris AM; Schneider PJ; Pedersen CA; Mirtallo JM
    Am J Health Syst Pharm; 2003 Dec; 60(24):2567-76. PubMed ID: 14735774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of drug content (potency) for compounded and FDA-approved formulations of doxycycline on receipt and after 21 days of storage.
    KuKanich K; KuKanich B; Slead T; Warner M
    J Am Vet Med Assoc; 2017 Oct; 251(7):835-842. PubMed ID: 28967825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of codeine phosphate in an extemporaneously compounded syrup.
    Dentinger PJ; Swenson CF
    Am J Health Syst Pharm; 2007 Dec; 64(24):2569-73. PubMed ID: 18056945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel physico-chemically and microbiologically stable oral solution of flecainide for pediatrics.
    Santoveña A; Charola I; Suárez-González J; Teigell-Pérez N; García-van Nood S; Soriano M; Fariña JB
    Pharm Dev Technol; 2018 Dec; 23(10):978-985. PubMed ID: 27658320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical compatibility of magnesium sulfate and sodium bicarbonate in a pharmacy-compounded hemofiltration solution.
    Moriyama B; Henning SA; Jin H; Kolf M; Rehak NN; Danner RL; Walsh TJ; Grimes GJ
    Am J Health Syst Pharm; 2010 Apr; 67(7):562-5. PubMed ID: 20237384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy.
    Karara AH; Hines R; Demir Z; Nnorom B; Horsey R; Twigg G
    Int J Pharm Compd; 2016; 20(6):461-467. PubMed ID: 28339384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients.
    García MC; Manzo RH; Jimenez-Kairuz AF
    Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy.
    Moehring RW; Lewis SS; Isaacs PJ; Schell WA; Thomann WR; Althaus MM; Hazen KC; Dicks KV; Lipuma JJ; Chen LF; Sexton DJ
    JAMA Intern Med; 2014 Apr; 174(4):606-12. PubMed ID: 24493147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploratory analysis for the implementation of antineoplastic logarithmic dose banding.
    Albert-Marí A; Valero-García S; Fornés-Ferrer V; Poveda-Andrés JL
    Int J Clin Pharm; 2018 Oct; 40(5):1281-1291. PubMed ID: 30097820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving policies and practices for the extemporaneous compounding of oral liquid dosage forms in Saudi Arabian hospitals.
    Joosub I; Emara Z; Gray A
    Eur J Hosp Pharm; 2021 Sep; 28(5):280-283. PubMed ID: 34426482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective survey of compounded medications for children in Japan.
    Saito J; Akabane M; Ishikawa Y; Iwahashi K; Nakamura H; Yamatani A
    Eur J Pharm Biopharm; 2020 Oct; 155():122-127. PubMed ID: 32853693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review.
    Cutaia K; Chablani L; Zhao F
    Int J Pharm Compd; 2018; 22(6):480-489. PubMed ID: 30384349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxycycline concentration over time after storage in a compounded veterinary preparation.
    Papich MG; Davidson GS; Fortier LA
    J Am Vet Med Assoc; 2013 Jun; 242(12):1674-8. PubMed ID: 23725430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compounding practices in a Portuguese community pharmacy.
    Reis M; Carvalho M; Rodrigues A
    Int J Pharm Compd; 2014; 18(5):392-5. PubMed ID: 25577888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Availability of age-appropriate paediatric formulations in the Netherlands: the need in daily clinical practice remains.
    van der Vossen A; Buljaç S; Akçay K; Brugma JD; Vulto A; Hanff L
    Eur J Hosp Pharm; 2021 Nov; 28(6):306-312. PubMed ID: 34697046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations.
    Allen LV
    Int J Pharm Compd; 2019; 23(2):135-143. PubMed ID: 31085779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of ethanol and other potentially harmful excipients in pediatric oral medicines: survey of community pharmacies in a Nigerian City.
    Soremekun R; Ogbuefi I; Aderemi-Williams R
    BMC Res Notes; 2019 Jul; 12(1):460. PubMed ID: 31349864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
    Pabari RM; McDermott C; Barlow J; Ramtoola Z
    Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Trends and Emerging Priorities in Compounded Preparations for Children.
    Parrish RH
    Int J Pharm Compd; 2018; 22(5):358-366. PubMed ID: 30384335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.